Hetero Labs competitive analysis

Latest publications and patents of Hetero Labs New

Explore the latest publications and patents granted to Hetero Labs, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Hetero Labs against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The PatientGENZYMEMay 14, 2020

Latest PTAB cases involving Hetero Labs

Discover the latest PTAB cases involving Hetero Labs, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hetero Labs with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
HETERO LABS1 - - - Highly Aggressive
GENZYME - 1925Defensive